Fresita Proteins Approves ₹89.76 Crore Rights Issue Terms and Schedule
Sarda Proteins Ltd · Outcome · 27 Oct 2026, 12:17 am
Fresita Proteins Approves ₹89.76 Crore Rights Issue Terms and Schedule Fresita Proteins Limited approved the terms for its rights issue of up to 74,79,917 fully paid-up equity shares (face value ₹10) at ₹120 per share (₹110 premium), raising up to ₹89.76 crore. The rights entitlement ratio is set at 5:6 (5 rights shares for every 6 shares held), with the record date fixed for 30th Oct'26. The issue opens on 12th Nov'26 and closes on 26th Nov'26. Outstanding equity shares will expand from 89,75,900 to 1,64,55,817 post-issue upon full subscription. Listing is targeted for 30th Nov'26.
Original exchange filing (PDF)
More announcements from Sarda Proteins Ltd
- As Per Attachment · 30 Oct 2026
- Outcome of Board Meeting_30-10-2026 · 30 Oct 2026
- Letter of Offer for the Rights issue · 30 Oct 2026
- Fresita Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve the Unaudited Standalone Financial .... · 30 Oct 2026
- Fresita Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve matter in connection with .... · 21 Oct 2026
- Scrutinizer''s Report · 02 Oct 2026
- ATTACHED HEREWITH PROCEEDING OF 35TH AGM · 30 Sept 2026
- Clarification of Price Movement · 17 Sept 2026
